Week 262 Review - A super duper week!

What an absolutely terrific week. There were gains in some of my bigger holdings and some spectacular gains that I haven't experienced since I started this 5 years ago. The portfolio climbed by £11,315 and the deficit between cost and value narrowed to £18.764. The best news is the total portfolio passed the magic £100K milestone and stands at £102,077.

There were no big fallers this week. A rare state of affairs!

JLP:Jubilee Metals had another good week, rising 5% in my SIPP and 4% in my ISA. Both these accounts are in profit and I think there's a long way to go yet.

TLOU:Tlou Energy only climbed 0.1p, but that was 5% in my trading account. I really need some good news for these to shift, but still happy I forked out for some more in the recent open offer.

SAE:Simec Atlantis Energy had a bit of a surge, climbing 6%. At 76% down these are a long way from being in profit, but if they rise another 1% they go from red to crimson, which is always a bit of a morale boost.

OPTI:Optibiotix climbed 8p which would normally be a shoe-in for Share of the Week as it's 12% and worth £8,900 of this week's rise. However, this was such a good week there are 2 shares beating it. There's a big surge of support in the probiotics sector following successful phase III results for Nasdaq listed Seres Therapeutics, and I'm really hoping this will see a continued interest in OPTI from new investors. There's certainly a lot of new faces on the bulletin board.

N4P:N4 Pharma climbed 23% after news that something vaguely positive happened with using their Nuvec system to deliver a Covid-19 vaccine. I'm still not convinced, but if the Covid bandwagon is enough to give me an escape route, I'll gladly take it at the first opportunity.

Share of the week is my recent purchase DDDD:4D Pharma, which soared 87% from a 3% loss to 84% profit. Quite stunning, and all on the back of the Seres Therapeutics news. It's now making £1,220 potential profit in just a few weeks, but I think it could rapidly go to over £4,000 profit and more as it has a staggering patent portfolio and Merck is a major shareholder.

Now we have evidence probiotic pharma treatment can work, this could be really big. I still prefer the business model OPTI:Optibiotix have taken, focusing on supplements to get profitable, and then pharma later, but DDDD have jumped straight into the pharma route and it seems to be finally paying off, albeit after the share price dwindled from 1000p 5 years ago to about 24p in March.That makes OPTI's performance over the last 5 years dropping from 90p to 60p look pretty great!

Weeeee!

It won't take much more and the 12-month trend line of misery will be pointing the right way.

The ISA and share portfolios look like this

			Weekly Change
Cash	£10.73		+£0
Portfolio cost	£62,366.49		+£0
Portfolio sell value (bid price-commission)	£51,104.00	(-18.1%)	+£5,751.33
Potential profits	£1,367.94		+£284.30
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£0		+£0
Yr 6 Average monthly cash profit	-£8.13	(-0.2%)	+£8.13
Total Dividends	£1,343.15		+£0
Total Profit from sales	£20,426.61		+£0
Average monthly cash profit	£356.15	(6.9%)	-£1.36
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.2%		-0.1%
Compound performance	52%		+0%

Massive surge in value and nice increase in potential profits of £284 courtesy of JLP:Jubilee Metals. The offer price of OPTI:Optibiotix shares is now above my weighted average, and a 4p rise next week will see them back in profit. I'm actually starting to think that's nailed on, as lots of people will be looking at microbiome shares this week, and OPTI will be clear as one of the cheapest.

That's got us back to halfway between the injection line and the cost line, and in the best position for over a year.

I think the trend line will be pointing upwards in 2 weeks when we lose the peak on the left.

The SIPP looks like this after week 246

			Weekly Change
Cash	£63.85		+£0
Portfolio cost	£55,826.02		+£0
Portfolio sell value (bid price - commission)	£49,261.76	(-11.8%)	+£5,541.97
Potential profits	£1,934.17		+£1,391.40
Yr 5 Dividends	£77.92		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£765.90		+£0
Yr 5 Average monthly cash profit	£81.68	(1.8%)	-£2.21
Total Dividends	£1,977.16		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£13,315.00		+£0
Average monthly cash profit	£259.32	(5.6%)	-£1.06
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.4%		+0%
Compound performance	40%		+0%

A similar stonking rise in value to the ISA of £5,541 and a really impressive increase in potential profits of £1,391 which is mainly DDDD:4D Pharma. The key thing is 6 out of 13 shares are now in profit, and 3 more are quite close to being back in profit, with only 4 that are miles off, one of which is IQE:IQE and slowly recovering.

Average monthly performance continues to be poor, and may stay that way until next spring when I start selling some magic formula shares. I am counting on JLP:Jubilee Metals contributing a bit before then, but I won't sell until SBTX:SkinBioTherapeutics is cheap again as I have to be able to buy more than my original holding.

Much closer to the cost line than the injection line. An almost £30,000 rise since the Covid crash and way higher than we've been for over a year, although £10,000 has been added to the account.

This will take a bit more effort to turn around the trend line, as we're only just reaching the peaks from earlier in the year. It may not even change direction until we hit break-even.

The trading account looks like this after week 212

			Weekly Change
Cash	£220.72		+£0
Portfolio cost	£2,354.16		+£0
Portfolio sell value (bid price - commission)	£1,416.59	(-39.8%)	+£22.17
Potential profits	£0		+£0
Year 5 Dividends	£0		+£0
Year 5 Profit	£154.70		+£0
Yr 5 Average monthly cash profit	£167.59	(85.4%)	-£55.86
Dividends	£47.92		+£0
Profit from sales	£441.07		+£0
Average monthly cash profit	£9.99	(5.1%)	-£0.05
(Sold stocks profit + Dividends - Fees  / Months)

A tiny tick up as half the shares increased and half dropped. I may however be in for a bit of a wait before I get to sell anything.

I haven't recovered from the dip after buying TLOU:Tlou Energy the other week, but we are heading in the right direction.

Back on the right side of the line, and the line is going in the right direction.

Last week the virtual magic formula  portfolio was down 13.58% and this week it is only down by 11.37% so over a 2% rise. There are now 8 companies in profit, but FXPO:Ferrexpo is the only one I own. My other magic formula shares are therefore still below where they were when lockdown happened.

Let's check out the wish list from last week:

1. OPTI:Optibiotix SweetBiotix announcement. Still nothing so I'll keep this until it happens.
2. POLR:Polar Capital Holdings to get in profit. Yes! Up by 2% and making £19 potential profit.
3. SBTX to drop in price to 16p. Nope - this got even worse, with a climb to 27p offer price. Much patience is required, as I still think it will drop.
4. TLOU:Tlou Energy announce de-watering has resumed. Not yet so we'll keep this
   
5. IQE:IQE increase another 5% so we get a gradual climb to 100p. Nope - a slight drop this week so I'll keep this one running

For next week I'd like to add my 6 SIPP shares stay in potential profit and JLP:Jubilee Metals announce permission to process platinum rich tailings at DCM. Most important new wish is that OPTI:Optibiotix gets back into profit as that will boost my morale more than anything else.